Overcoming artefact: anticipation in 284 Portuguese kindreds with familial amyloid polyneuropathy (FAP) ATTRV30M

Background Early-onset (≤40 years) and later-onset (≥50 years) cases of familial amyloid polyneuropathy (FAP) ATTRV30M are not different entities, often coexisting in the same family, and showing anticipation (earlier age-at-onset (AO) in younger generations, usually associated with more severe phenotype). Historically, anticipation has been ascribed to ascertainment biases. Our aim was to study anticipation in a very large number of FAP kindreds, removing possible biases, and gain further insight into parent-of-origin effects. Methods We analysed 926 parent-offspring pairs (from the Unidade Clínica de Paramiloidose roster, collected in 70 years), both clinically observed and had well-established AO, correcting for intrafamilial correlations. Results Women had a significantly higher AO, either for daughters (mean: 33.70, SD: 6.84) vs sons (29.43, 6.08); or mothers (39.57, 11.75) vs fathers (35.62, 11.62). Also, 291 pairs showed marked anticipation (≥10 years); the transmitting parent was the mother in 203 pairs. Mother-son pairs showed larger anticipation (10.43, 9.34), while father-daughter pairs showed only a residual anticipation (1.23, 9.77). Gender of offspring and parents was highly significant (with no interaction). To remove possible biases, we repeated analyses: (1) excluding the proband; (2) removing pairs with simultaneous onset; and (3) excluding offspring born after 1960. Anticipation was found in all subsamples, with the same trend for a parent-of-origin effect. Noteworthy, parents with AO ≤40 years never had offspring with AO ≥50. Conclusions These findings confirm anticipation as a true biological phenomenon, also in FAP ATTRV30M. Acknowledgment of anticipation may have important clinical implications in genetic counselling of offspring and in follow-up of mutation carriers.

[1]  J. E. Friedman Anticipation in hereditary disease: the history of a biomedical concept , 2011, Human Genetics.

[2]  C. Bonaïti‐pellié,et al.  Penetrance estimation of TTR familial amyloid polyneuropathy (type I) in Brazilian families , 2009, European journal of neurology.

[3]  A. Paterson,et al.  Genetic anticipation: fact or artifact, genetics or epigenetics? , 1997, The Lancet.

[4]  G. Holmgren,et al.  Familial amyloidotic polyneuropathy in Sweden: a pedigree analysis. , 1993, Journal of medical genetics.

[5]  Frank Z. Stanczyk,et al.  Sex differences in β-amyloid accumulation in 3xTg-AD mice: Role of neonatal sex steroid hormone exposure , 2010, Brain Research.

[6]  A. Paterson,et al.  Evidence for genetic anticipation in non-Mendelian diseases. , 1996, American journal of human genetics.

[7]  S M Breathnach,et al.  Amyloid and amyloidosis. , 1988, Journal of the American Academy of Dermatology.

[8]  M. Saraiva,et al.  Genetic epidemiology of familial amyloid polyneuropathy in the Balearic Islands (Spain) , 2005, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[9]  G. Sirugo,et al.  Genetic anticipation in Portuguese kindreds with familial amyloidotic polyneuropathy is unlikely to be caused by triplet repeat expansions , 1999, Human Genetics.

[10]  A. Sousa,et al.  Genetic Study of Late-Onset in Hereditary Amyloid Neuropathy (HAN) — Type I (Portuguese, Andrade) , 1988 .

[11]  C. Bonaiti-Pellié,et al.  Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population , 2008, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[12]  Y. Ando,et al.  Change in the age of onset in patients with familial amyloidotic polyneuropathy type I. , 1995, Internal medicine.

[13]  C ANDRADE,et al.  A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. , 1952, Brain : a journal of neurology.

[14]  I. Cardoso,et al.  Gender-dependent transthyretin modulation of brain amyloid-β levels: evidence from a mouse model of Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.

[15]  J. R. Pilsner,et al.  DNA methylation in schizophrenia subjects: gender and MTHFR 677C/T genotype differences. , 2012, Epigenomics.

[16]  M. MacDonald,et al.  Huntington's disease: the case for genetic modifiers , 2009, Genome Medicine.

[17]  G. Sobue,et al.  Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity. , 2002, Neurology.

[18]  F. McMahon,et al.  Anticipation in bipolar affective disorder. , 1993, American journal of human genetics.

[19]  J. Sequeiros,et al.  Onset in the seventh decade and lack of symptoms in heterozygotes for the TTRMet30 mutation in hereditary amyloid neuropathy-type I (Portuguese, Andrade). , 1987, American journal of medical genetics.

[20]  F. Fraser,et al.  Trinucleotide repeats not the only cause of anticipation , 1997, The Lancet.

[21]  G. Holmgren,et al.  Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. , 1993, Human heredity.

[22]  R. Griggs,et al.  Evidence for anticipation and association of deletion size with severity in facioscapulohumerd muscular dystrophy , 1996 .

[23]  M. Benson Pathogenesis of transthyretin amyloidosis , 2012, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[24]  N. Yanagisawa,et al.  A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy. , 1998, Journal of medical genetics.

[25]  Arturas Petronis,et al.  Epigenetic approaches to psychiatric disorders , 2010, Dialogues in clinical neuroscience.

[26]  A. Sousa,et al.  Genetic epidemiology of familial amyloidotic polyneuropathy (FAP)-type I in Póvoa do Varzim and Vila do Conde (north of Portugal). , 1995, American journal of medical genetics.

[27]  C. Bonaïti‐pellié,et al.  Parent-of-origin effect in transthyretin related amyloid polyneuropathy , 2009, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[28]  J. Geraedts,et al.  Anticipation in myotonic dystrophy: fact or fiction? , 1989, Brain : a journal of neurology.

[29]  G. Winberg,et al.  DNA-Encoding Enzymatically Active HIV-1 Reverse Transcriptase, but Not the Inactive Mutant, Confers Resistance to Experimental HIV-1 Challenge , 2001, Intervirology.

[30]  L. Penrose The problem of anticipation in pedigrees of dystrophia myotonica. , 1948, Annals of eugenics.

[31]  R. Griggs,et al.  Evidence for anticipation and association of deletion size with severity in facioscapulohumeral muscular dystrophy. The FSH-DY Group. , 1996, Annals of neurology.

[32]  W. Reardon,et al.  Anticipation in myotonic dystrophy: new light on an old problem. , 1992, American journal of human genetics.